Overexpression of hepatic plasminogen activator inhibitor type 1 mRNA in rabbits with fatty liver

Table 1 The changes of body mass and liver index

Groups	n	m (body)/(kg)		Liver index /(g•kg¯¹) End
		Start	End
Control	7	2.4 ± 0.3	3.1 ± 0.2	26 ± 3
Model	10	2.3 ± 0.6	3.4 ± 0.1a	31 ± 2a

^aP ＜ 0.05 vs control.

Table 2 Plasma biochemical test at the 12th week

Groups	n	c (TG)/(mmol•L¯¹)	c (TCh)/(mmol•L¯¹)	b (ALT)/(nkat•L¯¹)	b (AST)/(nkat•L¯¹)
Control	7	0.34 ± 0.11	0.76 ± 0.17	372 ± 130	215 ± 45
Model	10	0.54 ± 0.17b	26.40 ± 3.89b	505 ± 215	263 ± 127

^bP ＜ 0.01 vs control.

Table 3 The changes of plasma PAI-1 activity (× 10³ AU•L¯¹)

Groups	n	0 wk	6 wk	12 wk
Control	7	5.6 ± 2.6	6.8 ± 1.4	4.8 ± 2.2
Model	10	4.9 ± 3.1	7.7 ± 1.1a	14.0 ± 2.5b

^aP ＜ 0.05,

^bP ＜ 0.01 vs control.